Ingredient
Cinchona Pubescens Bark Extract
Cinchona Pubescens Bark Extract is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is absorbed into the body and fetal development.
- Red Cinchona Bark Extract
- Quinine Tree Extract
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Cinchona Pubescens Bark Extract and pregnancy
Not Recommended
- Absorbed into the body
- Fetal development
Cinchona bark extract contains quinine alkaloids, compounds that have been extensively studied in their medicinal form. Quinine has historically been used to treat malaria, but in cosmetics it appears in much smaller concentrations for its antioxidant and astringent properties. The concern during pregnancy stems from quinine's known effects on the uterus and fetal development. According to the FDA, high-dose quinine (oral medication) is associated with uterine contractions and has been linked to birth defects when used in early pregnancy. While topical cosmetic concentrations are significantly lower than therapeutic doses, the potential for systemic absorption exists, especially with repeated use or compromised skin barrier. Most obstetricians and dermatologists recommend avoiding cinchona bark extract during pregnancy as a precautionary measure. The ACOG advises pregnant women to be cautious with botanical ingredients that contain pharmacologically active compounds. Given that safer alternatives exist for antioxidant benefits, many women choose to avoid this ingredient throughout pregnancy.
Cinchona Pubescens Bark Extract and breastfeeding
Not Recommended
- Passes into breast milk
- Infant exposure
Cinchona bark extract contains quinine alkaloids that can be absorbed through the skin, though at lower levels than oral administration. Quinine is known to pass into breast milk when taken orally as medication, and while cosmetic concentrations are much lower, dermatologists generally advise caution with ingredients containing pharmacologically active alkaloids. The concern for breastfeeding mothers is the potential for these compounds to reach breast milk and subsequently the infant. According to LactMed, the NIH's drug and lactation database, quinine does transfer to breast milk and can cause adverse effects in breastfed infants. While topical cosmetic use involves lower exposure than oral medication, the potential for accumulation with daily use exists. Most dermatologists and lactation consultants recommend avoiding cinchona bark extract while breastfeeding. The AAD notes that mothers should be particularly cautious with botanical ingredients that have medicinal properties. Safer antioxidant alternatives are widely available and provide similar skincare benefits without the theoretical risks to breastfed infants.
Cinchona Pubescens Bark Extract and postpartum
Safe to Use
- Irritant
- Common allergen
For postpartum women who are not breastfeeding, cinchona bark extract poses minimal concerns beyond standard cosmetic sensitivities. The ingredient can provide antioxidant benefits and help with skin tone, though its effectiveness is not as well-documented as other antioxidants. The primary considerations are potential irritation and allergic reactions, which can be more pronounced in postpartum skin that may be more sensitive due to hormonal changes. Patch testing is recommended before incorporating products with this ingredient into your routine, especially if you have a history of plant allergies or sensitive skin.
Cinchona Pubescens Bark Extract and trying to conceive
Caution Advised
- Absorbed into the body
- Builds up in tissue
Women trying to conceive should consider discontinuing cinchona bark extract products as they prepare for pregnancy. While topical cosmetic use involves much lower concentrations than medicinal quinine, the presence of pharmacologically active alkaloids suggests a cautious approach is warranted. Since pregnancy can occur before confirmation, and the first trimester is the most critical period for fetal development, many healthcare providers recommend avoiding ingredients with known pregnancy concerns during the TTC period. The body's ability to eliminate these compounds varies by individual, so allowing time for clearance before conception is a common recommendation. Switching to proven-safe alternatives for antioxidant benefits is a simple precautionary measure.
Cinchona Pubescens Bark Extract and PCOS
Safe to Use
Cinchona bark extract does not have known hormonal effects or interactions with androgen pathways, making it generally safe for women with PCOS. The ingredient's antioxidant and anti-inflammatory properties may actually be beneficial for managing some PCOS-related skin concerns. Women with PCOS often experience inflammatory skin conditions including acne and hyperpigmentation. The extract's astringent and antioxidant properties can help with oil control and inflammation, though other ingredients like niacinamide and azelaic acid are better studied for PCOS-specific concerns. As with any botanical ingredient, individual sensitivity varies. If you have reactive skin or experience increased sensitivity due to PCOS-related hormonal fluctuations, monitor how your skin responds. The ingredient does not interfere with PCOS medications or hormonal treatments.
Cinchona Pubescens Bark Extract and general use
Safe to Use
- Common allergen
- Irritant
For the general population not pregnant or breastfeeding, cinchona bark extract is considered relatively safe in cosmetic formulations. The ingredient provides antioxidant benefits and has astringent properties that can help with skin texture and tone. Cosmetic concentrations are significantly lower than therapeutic quinine levels. The primary concerns are allergic reactions and skin irritation. Some individuals may experience contact dermatitis, redness, or sensitivity, particularly those with allergies to plants in the Rubiaceae family. As with any botanical ingredient, individual reactions vary, and patch testing is advisable before full application. The ingredient is approved for use in cosmetics in both the EU and US markets. While it's not as extensively studied as some mainstream actives, its traditional use in skincare and the absence of widespread safety concerns suggest it can be used safely by most people. If you experience any irritation, discontinue use and consult a dermatologist.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Cinchona Pubescens Bark Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store